Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
3.680
+0.080 (2.22%)
At close: Sep 30, 2026, 4:00 PM EDT
3.770
+0.090 (2.45%)
After-hours: Sep 30, 2026, 5:11 PM EDT
Bolt Biotherapeutics Employees
Bolt Biotherapeutics had 23 employees as of December 31, 2025. The number of employees decreased by 29 or -55.77% compared to the previous year.
Employees
23
Change
-29
Growth
-55.77%
Revenue / Employee
$204,348
Profits / Employee
-$1,249,522
Market Cap
7.09M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 23 | -29 | -55.77% |
| Sep 30, 2025 | 40 | -12 | -23.08% |
| Dec 31, 2024 | 52 | -48 | -48.00% |
| Dec 31, 2023 | 100 | 6 | 6.38% |
| Dec 31, 2022 | 94 | 3 | 3.30% |
| Dec 31, 2021 | 91 | 26 | 40.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Lunai Bioworks | 29 |
| Imunon | 20 |
| Soligenix | 14 |
| Azitra | 13 |
| CNS Pharmaceuticals | 8 |
| Enveric Biosciences | 6 |
| Acurx Pharmaceuticals | 4 |
BOLT News
- 7 weeks ago - Bolt Biotherapeutics reports Q2 EPS ($4.57) vs. ($4.46) last year - TheFly
- 7 weeks ago - Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Bolt Biotherapeutics Earnings release: Q2 2026 - Filings
- 7 weeks ago - Bolt Biotherapeutics Quarterly report: Q2 2026 - Filings
- 3 months ago - Bolt Metals Announces Closing of Option to Acquire the High-Grade Floralia Iron Project - Accesswire
- 4 months ago - Bolt Biotherapeutics initiated with a Buy at Rodman & Renshaw - TheFly
- 4 months ago - Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Bolt Biotherapeutics Quarterly report: Q1 2026 - Filings